FDA Inspection 1030729 — Jin Jie, MD

Jin Jie, MD — FEI 3013641657

The FDA completed an inspection of Jin Jie, MD on Nov 2, 2017 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 2, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hangzhou (China)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.